3 Stocks to Buy if a Coronavirus Vaccine Comes Out
Right now, there are 50 coronavirus vaccine candidates in clinical trials worldwide, and there is a good chance that at least one of them can earn approval from the U.S. Food and Drug Administration (FDA). If that happens, any business that had its revenues hit hard by COVID-19 could witness a full-on recovery and major gains in its stock price. This could happen sooner than we think; Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) are set to publish results on large-scale testing of their experimental coronavirus vaccine next month, and 10 other candidates are in phase 3 clinical trials.
